{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:19Z","timestamp":1791639559268,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chebulinic acid (CA), originally isolated from the flower extract of the plant<jats:italic>Terminalia chebula<\/jats:italic>, has been shown to inhibit infection of herpes simplex virus-2 (HSV-2), suggestively by inhibiting the host entry step of viral infection. Like HSV-2, the dengue virus (DENV) and chikungunya virus (CHIKV) also use receptor glycosaminoglycans (GAG) to gain host entry, therefore, the activity of CA was tested against these viruses. Co-treatment of 8\u00a0\u00b5M CA with DENV-2 caused 2 log decrease in the virus titer (4.0 log<jats:sub>10<\/jats:sub>FFU\/mL) at 120\u00a0h post infection, compared to virus control (5.95 log<jats:sub>10<\/jats:sub>FFU\/mL). In contrast, no inhibitory effect of CA was observed against CHIKV infection under any condition. The mechanism of action of CA was investigated in silico by employing DENV-2 and CHIKV envelope glycoproteins. During docking, CA demonstrated equivalent binding at multiple sites on DENV-2 envelope protein, including GAG binding site, which have previously been reported to play a crucial role in host attachment and fusion, indicating blocking of these sites. However, CA did not show binding to the GAG binding site on envelope protein-2 of CHIKV. The in vitro and in silico findings suggest that CA possesses the ability to inhibit DENV-2 infection at the entry stage of its infection cycle and may be developed as a potential therapeutic agent against it.<\/jats:p>","DOI":"10.1038\/s41598-022-13923-6","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T10:04:03Z","timestamp":1655805843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Studies on the antiviral activity of chebulinic acid against dengue and chikungunya viruses and in silico investigation of its mechanism of inhibition"],"prefix":"10.1038","volume":"12","author":[{"given":"Naiju","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalichamy","family":"Alagarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Tapryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"13923_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrmicro1006","volume":"2","author":"SC Weaver","year":"2004","unstructured":"Weaver, S. C. & Barrett, A. D. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat. Rev. Microbiol. 2, 789\u2013801 (2004).","journal-title":"Nat. Rev. Microbiol."},{"key":"13923_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/BOR.0b013e328303220b","volume":"20","author":"A Toivanen","year":"2008","unstructured":"Toivanen, A. Alphaviruses: An emerging cause of arthritis?. Curr. Opin. Rheumatol. 20, 486\u2013490 (2008).","journal-title":"Curr. Opin. Rheumatol."},{"key":"13923_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/631642","volume":"2014","author":"D Parashar","year":"2014","unstructured":"Parashar, D. & Cherian, S. Antiviral perspectives for chikungunya virus. BioMed Res. Int. 2014, 1\u201311 (2014).","journal-title":"BioMed Res. Int."},{"key":"13923_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1179\/2047773214Y.0000000163","volume":"108","author":"G Rezza","year":"2014","unstructured":"Rezza, G. Dengue and chikungunya: Long-distance spread and outbreaks in na\u00efve areas. Pathog. Global Health 108, 349\u2013355 (2014).","journal-title":"Pathog. Global Health"},{"key":"13923_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2017-000530","volume":"3","author":"ES Paix\u00e3o","year":"2018","unstructured":"Paix\u00e3o, E. S., Teixeira, M. G. & Rodrigues, L. C. Zika, chikungunya and dengue: the causes and threats of new and re-emerging arboviral diseases. BMJ Glob. Health 3, e000530 (2018).","journal-title":"BMJ Glob. Health"},{"key":"13923_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","volume":"108","author":"RJ Kuhn","year":"2002","unstructured":"Kuhn, R. J. et al. Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion. Cell 108, 717\u2013725 (2002).","journal-title":"Cell"},{"key":"13923_CR7","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","volume":"75","author":"WD Crill","year":"2001","unstructured":"Crill, W. D. & Roehrig, J. T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 7769\u20137773 (2001).","journal-title":"J. Virol."},{"key":"13923_CR8","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","volume":"75","author":"SL Allison","year":"2001","unstructured":"Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W. & Heinz, F. X. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75, 4268\u20134275 (2001).","journal-title":"J. Virol."},{"key":"13923_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/096876899294706","volume":"16","author":"W Weissenhorn","year":"1999","unstructured":"Weissenhorn, W. et al. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16, 3\u20139 (1999).","journal-title":"Mol. Membr. Biol."},{"key":"13923_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nm0897-866","volume":"3","author":"Y Chen","year":"1997","unstructured":"Chen, Y. et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3, 866\u2013871 (1997).","journal-title":"Nat. Med."},{"key":"13923_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/sj.embor.embor866","volume":"4","author":"E Navarro-Sanchez","year":"2003","unstructured":"Navarro-Sanchez, E. et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 4, 723\u2013728 (2003).","journal-title":"EMBO Rep."},{"key":"13923_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040017","volume":"4","author":"JL Miller","year":"2008","unstructured":"Miller, J. L. et al. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 4, e17 (2008).","journal-title":"PLoS Pathog."},{"key":"13923_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/000080882","volume":"47","author":"S Jindadamrongwech","year":"2004","unstructured":"Jindadamrongwech, S. & Smith, D. R. Virus overlay protein binding assay (VOPBA) reveals serotype specific heterogeneity of dengue virus binding proteins on HepG2 human liver cells. Intervirology 47, 370\u2013373 (2004).","journal-title":"Intervirology"},{"key":"13923_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/jb\/mvj067","volume":"139","author":"C Aoki","year":"2006","unstructured":"Aoki, C. et al. Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2. J. Biochem. 139, 607\u2013614 (2006).","journal-title":"J. Biochem."},{"key":"13923_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1995-7645(14)60164-4","volume":"7","author":"AL Presti","year":"2014","unstructured":"Presti, A. L., Lai, A., Cella, E., Zehender, G. & Ciccozzi, M. Chikungunya virus, epidemiology, clinics and phylogenesis: A review. Asian Pac. J. Trop. Med. 7, 925\u2013932 (2014).","journal-title":"Asian Pac. J. Trop. Med."},{"key":"13923_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"SS Seyedi","year":"2016","unstructured":"Seyedi, S. S. et al. Computational approach towards exploring potential anti-chikungunya activity of selected flavonoids. Sci. Rep. 6, 1\u20138 (2016).","journal-title":"Sci. Rep."},{"key":"13923_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature09555","volume":"468","author":"JE Voss","year":"2010","unstructured":"Voss, J. E. et al. Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography. Nature 468, 709\u2013712 (2010).","journal-title":"Nature"},{"key":"13923_CR18","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.3390\/v7072792","volume":"7","author":"V Duijl-Richter","year":"2015","unstructured":"Duijl-Richter, V., Hoornweg, T. E., Rodenhuis-Zybert, I. A. & Smit, J. M. Early events in chikungunya virus infection: From virus cellbinding to membrane fusion. Viruses 7, 3647\u20133674 (2015).","journal-title":"Viruses"},{"key":"13923_CR19","doi-asserted-by":"publisher","first-page":"e00432","DOI":"10.1128\/JVI.00432-17","volume":"91","author":"A Tanaka","year":"2017","unstructured":"Tanaka, A. et al. Genome-wide screening uncovers the significance of N-sulfation of heparan sulfate as a host cell factor for chikungunya virus infection. J. Virol. 91, e00432 (2017).","journal-title":"J. Virol."},{"key":"13923_CR20","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/jmv.23403","volume":"84","author":"P Wintachai","year":"2012","unstructured":"Wintachai, P. et al. Identification of prohibitin as a chikungunya virus receptor protein. J. Med. Virol. 84, 1757\u20131770 (2012).","journal-title":"J. Med. Virol."},{"key":"13923_CR21","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.1128\/JVI.01025-13","volume":"87","author":"S Moller-Tank","year":"2013","unstructured":"Moller-Tank, S., Kondratowicz, A. S., Davey, R. A., Rennert, P. D. & Maury, W. Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J. Virol. 87, 8327\u20138341 (2013).","journal-title":"J. Virol."},{"key":"13923_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","volume":"557","author":"R Zhang","year":"2018","unstructured":"Zhang, R. et al. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature 557, 570\u2013574 (2018).","journal-title":"Nature"},{"key":"13923_CR23","first-page":"3353","volume":"159","author":"C Fongsaran","year":"2014","unstructured":"Fongsaran, C. et al. Involvement of ATP synthase \u03b2 subunit in chikungunya virus entry into insect cells. Adv. Virol. 159, 3353\u20133364 (2014).","journal-title":"Adv. Virol."},{"key":"13923_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/dna.2013.2193","volume":"33","author":"D Guo","year":"2014","unstructured":"Guo, D., Zhu, Q., Zhang, H. & Sun, D. Proteomic analysis of membrane proteins of vero cells: Exploration of potential proteins responsible for virus entry. DNA Cell Biol. 33, 20\u201328 (2014).","journal-title":"DNA Cell Biol."},{"key":"13923_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/26895293.2020.1856192","volume":"14","author":"SYM Lim","year":"2021","unstructured":"Lim, S. Y. M., Chieng, J. Y. & Pan, Y. Recent insights on anti-dengue virus (DENV) medicinal plants: Review on in vitro, in vivo and in silico discoveries. All Life 14, 1\u201333 (2021).","journal-title":"All Life"},{"key":"13923_CR26","unstructured":"Bhishagratna, K. L. An English translation of The Sushruta Samhita: Based on Original Sanskrit Text, Vol. 2. (Author, 1911)."},{"key":"13923_CR27","first-page":"497","volume":"4","author":"H Ma","year":"2010","unstructured":"Ma, H., Diao, Y., Zhao, D., Li, K. & Kang, T. A new alternative to treat swine influenza A virus infection: Extracts from Terminalia chebula Retz. Afr. J. Microbiol. Res. 4, 497\u2013499 (2010).","journal-title":"Afr. J. Microbiol. Res."},{"key":"13923_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ptr.832","volume":"15","author":"TG Kim","year":"2001","unstructured":"Kim, T. G. et al. Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus. Phytother. Res. 15, 718\u2013720 (2001).","journal-title":"Phytother. Res."},{"key":"13923_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.fitote.2014.09.014","volume":"99","author":"OS Ajala","year":"2014","unstructured":"Ajala, O. S., Jukov, A. & Ma, C.-M. Hepatitis C virus inhibitory hydrolysable tannins from the fruits of Terminalia chebula. Fitoterapia 99, 117\u2013123 (2014).","journal-title":"Fitoterapia"},{"key":"13923_CR30","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1128\/JVI.01492-10","volume":"85","author":"L-T Lin","year":"2011","unstructured":"Lin, L.-T. et al. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J. Virol. 85, 4386\u20134398 (2011).","journal-title":"J. Virol."},{"key":"13923_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1620-8","volume":"17","author":"A Kesharwani","year":"2017","unstructured":"Kesharwani, A. et al. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complement. Altern. Med. 17, 1\u201311 (2017).","journal-title":"BMC Complement. Altern. Med."},{"key":"13923_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0166-3542(92)90008-S","volume":"18","author":"H Nakashima","year":"1992","unstructured":"Nakashima, H. et al. Inhibition of human immunodeficiency viral replication by tannins and related compounds. Antiviral Res. 18, 91\u2013103 (1992).","journal-title":"Antiviral Res."},{"key":"13923_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0166-3542(95)00978-7","volume":"32","author":"TA Yukawa","year":"1996","unstructured":"Yukawa, T. A. et al. Prophylactic treatment of cytomegalovirus infection with traditional herbs. Antiviral Res. 32, 63\u201370 (1996).","journal-title":"Antiviral Res."},{"key":"13923_CR34","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1128\/jvi.70.6.3461-3469.1996","volume":"70","author":"BC Herold","year":"1996","unstructured":"Herold, B. C., Gerber, S. I., Belval, B. J., Siston, A. M. & Shulman, N. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. J. Virol. 70, 3461\u20133469 (1996).","journal-title":"J. Virol."},{"key":"13923_CR35","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1128\/JVI.75.17.7818-7827.2001","volume":"75","author":"JJ Mart\u0131\u0301nez-Barrag\u00e1n","year":"2001","unstructured":"Mart\u0131\u0301nez-Barrag\u00e1n, J. J. & del Angel R. M. Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection. J. Virol. 75, 7818\u20137827 (2001).","journal-title":"J. Virol."},{"key":"13923_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002719","volume":"8","author":"CL Gardner","year":"2014","unstructured":"Gardner, C. L. et al. Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: A model for rational arboviral vaccine design. PLoS Negl. Trop. Dis. 8, e2719 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13923_CR37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"13923_CR38","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.3390\/molecules26103016","volume":"26","author":"K Panda","year":"2021","unstructured":"Panda, K. et al. In vitro antiviral activity of \u03b1-mangostin against dengue virus serotype-2 (DENV-2). Molecules 26, 3016 (2021).","journal-title":"Molecules"},{"key":"13923_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-019-2695-1","volume":"19","author":"AI Trujillo-Correa","year":"2019","unstructured":"Trujillo-Correa, A. I. et al. In vitro and in silico anti-dengue activity of compounds obtained from Psidium guajava through bioprospecting. BMC Complement. Altern. Med. 19, 1\u201316 (2019).","journal-title":"BMC Complement. Altern. Med."},{"key":"13923_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-017-0895-1","volume":"14","author":"SA Abdul Ahmad","year":"2017","unstructured":"Abdul Ahmad, S. A. et al. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. Virol. J. 14, 1\u201313 (2017).","journal-title":"Virol. J."},{"key":"13923_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micinf.2006.09.009","volume":"9","author":"J Chin","year":"2007","unstructured":"Chin, J., Chu, J. & Ng, M. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microb. Infect. 9, 1\u20136 (2007).","journal-title":"Microb. Infect."},{"key":"13923_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1099\/vir.0.037317-0","volume":"93","author":"D Watterson","year":"2012","unstructured":"Watterson, D., Kobe, B. & Young, P. R. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding. J. Gen. Virol. 93, 72\u201382 (2012).","journal-title":"J. Gen. Virol."},{"key":"13923_CR43","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","volume":"100","author":"Y Modis","year":"2003","unstructured":"Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 100, 6986\u20136991 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"13923_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/adt.2010.0321","volume":"8","author":"D Shum","year":"2010","unstructured":"Shum, D. et al. High-content assay to identify inhibitors of dengue virus infection. Assay Drug Dev. Technol. 8, 553\u2013570 (2010).","journal-title":"Assay Drug Dev. Technol."},{"key":"13923_CR45","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"R Laskowski","year":"2011","unstructured":"Laskowski, R. & Swindells, M. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"13923_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. Des. Sel. 8, 127\u2013134 (1995).","journal-title":"Protein Eng. Des. Sel."},{"key":"13923_CR47","volume-title":"The PyMOL Molecular Graphics System, Version 2.0","author":"E Lilkova","year":"2015","unstructured":"Lilkova, E. et al. The PyMOL Molecular Graphics System, Version 2.0 (Schrodinger, 2015)."},{"key":"13923_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/femsre\/fuu004","volume":"39","author":"C Cruz-Oliveira","year":"2015","unstructured":"Cruz-Oliveira, C. et al. Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol. Rev. 39, 155\u2013170 (2015).","journal-title":"FEMS Microbiol. Rev."},{"key":"13923_CR49","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1021\/acs.jmedchem.8b01925","volume":"62","author":"MR Bauer","year":"2019","unstructured":"Bauer, M. R. & Mackey, M. D. Electrostatic complementarity as a fast and effective tool to optimize binding and selectivity of protein\u2013ligand complexes. J. Med. Chem. 62, 3036\u20133050 (2019).","journal-title":"J. Med. Chem."},{"key":"13923_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-020-00639-w","volume":"27","author":"A Sharma","year":"2020","unstructured":"Sharma, A., Vasanthapuram, R., Venkataswamy, M. & Desai, A. Prohibitin 1\/2 mediates dengue-3 entry into human neuroblastoma (SH-SY5Y) and microglia (CHME-3) cells. J. Biomed. Sci. 27, 1\u201317 (2020).","journal-title":"J. Biomed. Sci."},{"key":"13923_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.virol.2010.07.015","volume":"406","author":"A Kuadkitkan","year":"2010","unstructured":"Kuadkitkan, A., Wikan, N., Fongsaran, C. & Smith, D. R. Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells. Virology 406, 149\u2013161 (2010).","journal-title":"Virology"},{"key":"13923_CR52","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s10495-015-1143-z","volume":"20","author":"Y-T Peng","year":"2015","unstructured":"Peng, Y.-T., Chen, P., Ouyang, R.-Y. & Song, L. Multifaceted role of prohibitin in cell survival and apoptosis. Apoptosis 20, 1135\u20131149 (2015).","journal-title":"Apoptosis"},{"key":"13923_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. The I-TASSER suite: Protein structure and function prediction. Nat. Methods 12, 7\u20138 (2015).","journal-title":"Nat. Methods"},{"key":"13923_CR54","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"13923_CR55","doi-asserted-by":"publisher","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","volume":"50","author":"M Varadi","year":"2022","unstructured":"Varadi, M. et al. AlphaFold protein structure database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439\u2013D444 (2022).","journal-title":"Nucleic Acids Res."},{"key":"13923_CR56","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1042\/BSR20191077","volume":"39","author":"B Sahoo","year":"2019","unstructured":"Sahoo, B. & Chowdary, T. K. Conformational changes in chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2\u2013E1 dissociation during viral entry. Biosci. Rep. 39, 1077 (2019).","journal-title":"Biosci. Rep."},{"key":"13923_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000785","volume":"4","author":"V Tricou","year":"2010","unstructured":"Tricou, V. et al. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl. Trop. Dis. 4, e785 (2010).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13923_CR58","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/cid\/cis655","volume":"55","author":"DT Tam","year":"2012","unstructured":"Tam, D. T. et al. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: A randomized, placebo-controlled trial. Clin. Infect. Dis. 55, 1216\u20131224 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"13923_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-13-203","volume":"13","author":"J Whitehorn","year":"2012","unstructured":"Whitehorn, J. et al. Lovastatin for adult patients with dengue: Protocol for a randomised controlled trial. Trials 13, 1\u20136 (2012).","journal-title":"Trials"},{"key":"13923_CR60","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","volume":"14","author":"JG Low","year":"2014","unstructured":"Low, J. G. et al. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): A phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet. Infect. Dis 14, 706\u2013715 (2014).","journal-title":"Lancet. Infect. Dis"},{"key":"13923_CR61","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-823328\/v1","volume-title":"Impact of Treatment with Anti-Parasitic (Ivermectin) During Prepartum Period on Mastitis and Postpartum Reproductive Efficiency Measurements in Egyptian Baladi Cows","author":"AI Damarany","year":"2021","unstructured":"Damarany, A. I. Impact of Treatment with Anti-Parasitic (Ivermectin) During Prepartum Period on Mastitis and Postpartum Reproductive Efficiency Measurements in Egyptian Baladi Cows (Springer, 2021)."},{"key":"13923_CR62","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/infdis\/jis470","volume":"207","author":"NM Nguyen","year":"2013","unstructured":"Nguyen, N. M. et al. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J. Infect. Dis. 207, 1442\u20131450 (2013).","journal-title":"J. Infect. Dis."},{"key":"13923_CR63","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/13543784.2016.1201063","volume":"25","author":"H Beesetti","year":"2016","unstructured":"Beesetti, H., Khanna, N. & Swaminathan, S. Investigational drugs in early development for treating dengue infection. Expert Opin. Investig. Drugs 25, 1059\u20131069 (2016).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"13923_CR64","first-page":"1","volume":"6","author":"I Rodenhuis-Zybert","year":"2021","unstructured":"Rodenhuis-Zybert, I. & Van Der Schaar, H. JM da Silva Voorham et al., \u201cImmature dengue virus: A veiled pathogen?\u201d. PLoS Pathog. 6, 1\u201310 (2021).","journal-title":"PLoS Pathog."},{"key":"13923_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059211","volume":"8","author":"M Shah","year":"2013","unstructured":"Shah, M., Wadood, A., Rahman, Z. & Husnain, T. Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-sign, an in-silico approach. PLoS ONE 8, e59211 (2013).","journal-title":"PLoS ONE"},{"key":"13923_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/10799893.2012.752006","volume":"33","author":"T-B Zhou","year":"2013","unstructured":"Zhou, T.-B. & Qin, Y.-H. Signaling pathways of prohibitin and its role in diseases. J. Recept. Signal Transduction 33, 28\u201336 (2013).","journal-title":"J. Recept. Signal Transduction"},{"key":"13923_CR67","first-page":"1065","volume":"19","author":"T Yoshinaka","year":"2019","unstructured":"Yoshinaka, T. et al. Structural basis of mitochondrial scaffolds by prohibitin complexes: Insight into a role of the coiled-coil region. Science 19, 1065\u20131078 (2019).","journal-title":"Science"},{"key":"13923_CR68","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Y Modis","year":"2004","unstructured":"Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313\u2013319 (2004).","journal-title":"Nature"},{"key":"13923_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166474","volume":"11","author":"YL Lo","year":"2016","unstructured":"Lo, Y. L. et al. Dengue virus infection is through a cooperative interaction between a mannose receptor and CLEC5A on macrophage as a multivalent hetero-complex. PLoS ONE 11, e0166474 (2016).","journal-title":"PLoS ONE"},{"key":"13923_CR70","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/emmm.201200213","volume":"4","author":"YW Kam","year":"2012","unstructured":"Kam, Y. W. et al. Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO Mol. Med. 4, 330\u2013343 (2012).","journal-title":"EMBO Mol. Med."},{"key":"13923_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002423","volume":"7","author":"S Selvarajah","year":"2013","unstructured":"Selvarajah, S. et al. A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease. PLoS Negl. Trop. Dis. 7, e2423 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13923_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-021-01517-z","volume":"18","author":"P Patil","year":"2021","unstructured":"Patil, P. et al. In vitro and in vivo studies reveal \u03b1-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus. Virol. J. 18, 1\u201312 (2021).","journal-title":"Virol. J."},{"key":"13923_CR73","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1074\/jbc.M110.162685","volume":"286","author":"Z Jin","year":"2011","unstructured":"Jin, Z., Deval, J., Johnson, K. A. & Swinney, D. C. Characterization of the elongation complex of dengue virus RNA polymerase: assembly, kinetics of nucleotide incorporation, and fidelity. J. Biol. Chem. 286, 2067\u20132077 (2011).","journal-title":"J. Biol. Chem."},{"key":"13923_CR74","unstructured":"Rasband, W. S. National Institutes of Health. http:\/\/imagej.nih.gov\/ij\/ (2011)."},{"key":"13923_CR75","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13923-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T13:39:37Z","timestamp":1700746777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13923-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13923"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13923-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10397"}}